ATAI Life Sciences NV
NASDAQ:ATAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ATAI Life Sciences NV
Selling, General & Administrative
ATAI Life Sciences NV
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Selling, General & Administrative
-$63.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Selling, General & Administrative
-€14.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Merck KGaA
XETRA:MRK
|
Selling, General & Administrative
-€5.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Selling, General & Administrative
-€1.1m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Selling, General & Administrative
-€435.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
A
|
Apontis Pharma AG
XETRA:APPH
|
Selling, General & Administrative
-€17m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
Glance View
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.
See Also
What is ATAI Life Sciences NV's Selling, General & Administrative?
Selling, General & Administrative
-63.7m
USD
Based on the financial report for Dec 31, 2025, ATAI Life Sciences NV's Selling, General & Administrative amounts to -63.7m USD.
What is ATAI Life Sciences NV's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
5%
Over the last year, the Selling, General & Administrative growth was -39%. The average annual Selling, General & Administrative growth rates for ATAI Life Sciences NV have been 3% over the past three years , 5% over the past five years .
